Advances in the pathophysiology of status epilepticus

Acta Neurologica Scandinavica

Volumn 115, Issue SUPPL.186, 2007, Pages 7-15

  Chen, J W Y ^a   Naylor, D E ^a   Wasterlain, C G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMPA RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ANTICONVULSIVE AGENT; GLUTAMATE RECEPTOR; NEUROPEPTIDE;

CLINICAL FEATURE; CONFERENCE PAPER; CYTOPLASM; DISEASE COURSE; DRUG RESISTANCE; EPILEPTIC STATE; EPILEPTOGENESIS; HUMAN; MEMBRANE DEPOLARIZATION; RECEPTOR BINDING; SYNAPTIC MEMBRANE; ANIMAL; BRAIN; DRUG EFFECT; METABOLISM; NERVE DEGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURONS; RECEPTORS, GABA; STATUS EPILEPTICUS; SYNAPTIC TRANSMISSION; ANTICONVULSANTS; BRAIN; DRUG RESISTANCE; NERVE DEGENERATION; NEUROPEPTIDES; RECEPTORS, GABA-A; RECEPTORS, GLUTAMATE;

EID: 33847723101     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00803.x     Document Type: Conference Paper

References (79)

1. TROUSSEAU A. Lectures on clinical medicine delivered at the Hotel Dieu, Paris, Vol 1. Translated by Bazire PV. London: New Sydenham Society, 1868.
2. SHORVON S. Status epilepticus; its clinical features and treatment in children and adults, 1st edn. Cambridge: Cambridge University Press, 1994.
3. BOURNEVILLE DM (ed.). L'etat de mal epileptique. In: Recherches cliniques et therapeutiques sur l'epilepsie et l'hysterie. Compte-rendu des observations recueillies à la Salpétrière. Paris: Delahaye, 1876.
4. CLARK LP, PROUT TP. Status epilepticus: a clinical and pathological study in epilepsy. (An article in 3 parts.) Am J Insanity 1903;60:291-306;
5. 60:645-75;
6. 61:81-108.
7. MAZARATI AM, WASTERLAIN CG, SANKAR R, SHIN D. Self-sustaining status epilepticus after brief electrical stimulation of the perforant path. Brain Res 1998;801:251-3.
8. TREIMAN DM, MEYERS PD, WALTON NY et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-8.
9. CHEN JW, WASTERLAIN CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006;5:246-56.
10. DE LORENZO RJ, GARNETT LK, TOWNE AR et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 min. Epilepsia 1999;40:164-9.
11. DE LORENZO RJ, HAUSER WA, TOWNE AR et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-35.
12. AICARDI J, CHEVRIE JJ. Consequences of status epilepticus in infants and children. Adv Neurol 1983;34:115-25.
13. MAYTAL J, SHINNAR S, MOSHE SL, ALVAREZ LA. Low morbidity and mortality of status epilepticus in children. Pediatrics 1989;83:323-31.
14. O'REGAN ME, BROWN JK. Serum neuron specific enolase: a marker for neuronal dysfunction in children with continuous EEG epileptiform activity. Eur J Paediatr Neurol 1998;2:193-7.
15. VANLANDINGHAM KE, LOTHMAN EW. Self-sustaining limbic status epilepticus. I. Acute and chronic cerebral metabolic studies: limbic hypermetabolism and neocortical hypometabolism. Neurology 1991;41:1942-9.
16. FREEMAN JL, COLEMAN LT, SMITH LJ, SHIELD LK. Hemiconvulsion-hemiplegia-epilepsy syndrome: characteristic early magnetic resonance imaging findings. J Child Neurol 2002;17:10-6.
17. LANSBERG MG, O'BRIEN MW, NORBASH AM, MOSELEY ME, MORRELL M, ALBERS GW. MRI abnormalities associated with partial status epilepticus. Neurology 1999;52:1021-7.
18. LAZEYRAS F, BLANKE O, ZIMINE I, DELAVELLE J, PERRIG SH, SEECK M. MRI, (1)H-MRS, and functional MRI during and after prolonged nonconvulsive seizure activity. Neurology 2000;55:1677-82.
19. MEN S, LEE DH, BARRON JR, MUNOZ DG. Selective neuronal necrosis associated with status epilepticus: MR findings. AJNR Am J Neuroradiol 2000;21:1837-40.
20. MORIMOTO T, FUKUDA M, SUZUKI Y, KUSU M, KIDA K. Sequential changes of brain CT and MRI after febrile status epilepticus in a 6-year-old girl. Brain Dev 2002;24:190-3.
21. NIXON J, BATEMAN D, MOSS T. An MRI and neuropathological study of a case of fatal status epilepticus. Seizure 2001;10:588-91.
22. PASCUAL-CASTROVIEJO I, PASCUAL-P ASCUAL SI, PENA W, TALAVERA M. Status epilepticus-induced brain damage and opercular syndrome in childhood. Dev Med Child Neurol 1999;41:420-3.
23. LEPPIK IE, DERIVAN AT, HOMAN RW, WALKER J, RAMSAY RE, PATRICK B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-4.
24. ALLDREDGE BK, GELB AM, ISAACS SM et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631-7.
25. GASTAUT H. Classification of status epilepticus. Adv Neurol 1983;34:15-35.
26. GASTAUT H. A propos d' une classification symptomatologique des etats de mal epileptiques. In: Gastaut H, Roger J, Lob H, eds. Les etats de mal epileptiques. Paris: Masson, 1967:1-8.
27. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993;270:854-9.
28. BLECK TP. Convulsive disorders: status epilepticus. Clin Neuropharmacol 1991;14:191-8.
29. WASTERLAIN CG. Definition and classification of status epilepticus. The International Meeting on Status Epilepticus, Santa Monica, CA, 1997.
30. LOWENSTEIN DH, BLECK T, MACDONALD RL. It's time to revise the definition of status epilepticus. Epilepsia 1999;40:120-2.
31. MELDRUM BS. The revised operational definition of generalised tonic-clonic (TC) status epilepticus in adults. Epilepsia 1999;40:123-4.
32. WASTERLAIN CG. Mortality and morbidity from serial seizures. An experimental study. Epilepsia 1974;15:155-76.
33. FUJIKAWA DG. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res 1996;725:11-22.
34. MAZARATI AM, BALDWIN RA, SANKAR R, WASTERLAIN CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998;814:179-85.
35. A receptors. J Neurosci 1997;17:7532-40.
36. WASTERLAIN CG, CHEN J. Definition and classification of status epilepticus. In: Wasterlain CG, Treiman DM, eds. Status epilepticus, 1st edn. Boston, MA: MIT Press, 2006:11-16.
37. SHORVON S. The management of status epilepticus. J Neurol Neurosurg Psychiatry 2001;70(Suppl. 2):II22-7.
38. TREIMAN DM, WALTON NY, KENDRICK C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990;5:49-60.
39. DE CAMPOS CJ, CAVALHEIRO EA. Modification of the 'kindling' method for obtaining experimental status epilepticus in rats. Arq Neuropsiquiatr 1980;38:81-8.
40. MCINTYRE DC, NATHANSON D, EDSON N. A new model of partial status epilepticus based on kindling. Brain Res 1982;250:53-63.
41. BUTERBAUGH GG, MICHELSON HB, KEYSER DO. Status epilepticus facilitated by pilocarpine in amygdala-kindled rats. Exp Neurol 1986;94:91-102.
42. MILGRAM NW, GREEN I, LIBERMAN M, RIEXINGER K, PETIT TL. Establishment of status epilepticus by limbic system stimulation in previously unstimulated rats. Exp Neurol 1985;88:253-64.
43. MORRISETT RA, JOPE RS, SNEAD OC III. Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp Neurol 1987;97:193-200.
44. CAIN DP, MCKITRICK DJ, BOON F. Rapid and reliable induction of partial status epilepticus in naive rats by low-frequency (3-Hz) stimulation of the amygdala. Epilepsy Res 1992;12:51-5.
45. TABER KH, MCNAMERA JJ, ZORNETZER SF. Status epilepticus: a new rodent model. Electroencephalogr Clin Neurophysiol 1977;43:707-24.
46. LOTHMAN EW, BERTRAM EH, BEKENSTEIN JW, PERLIN JB. Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: electrographic and behavioral characteristics. Epilepsy Res 1989;3:107-19.
47. LOTHMAN EW, BERTRAM EH, KAPUR J, STRINGER JL. Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus. Epilepsy Res 1990;6:110-8.
48. VICEDOMINI JP, NADLER JV. Stimulation-induced status epilepticus: role of the hippocampal mossy fibers in the seizures and associated neuropathology. Brain Res 1990;512:70-4.
49. MAZARATI AM, WASTERLAIN CG. N-Methyl-D- asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett 1999;265:187-90.
50. WASTERLAIN CG, MAZARATI AM, NAYLOR D et al. Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus. Epilepsia 2002;43(Suppl. 5):20-9.
51. NAYLOR DE, LIU H, WASTERLAIN CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 2005;25:7724-33.
52. LIU H, MAZARATI AM, KATSUMORI H, SANKAR R, WASTERLAIN CG. Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc Natl Acad Sci U S A 1999;96:5286-91.
53. VEZZANI A, SPERK G, COLMERS WF. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 1999;22:25-30.
54. SPERK G, WIESER R, WIDMANN R, SINGER EA. Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin. Neuroscience 1986;17:1117-26.
55. SPERK G, MARKSTEINER J, GRUBER B, BELLMANN R, MAHATA M, ORTLER M. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience 1992;50:831-46.
56. MAZARATI AM, LIU H, SOOMETS U et al. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 1998;18:10070-7.
57. MAZARATI A, LIU H, WASTERLAIN C. Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus. Neuroscience 1999;89:167-73.
58. WASTERLAIN CG. Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations. Neurology 1974;24:175- 80.
59. NAYLOR DE, WASTERLAIN CG. GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation. Epilepsia 2005;46(Suppl. 5):142-7.
60. WASTERLAIN CG, LIU H, MAZARATI A, BALDWIN RA. NMDA receptor trafficking during the transition from single seizures to status epilepticus. Ann Neurol 2002;52(Suppl. 1):S16.
61. WASTERLAIN CG, BRONSTEIN JM, MORIN AM, DWYER BE, SANKAR R. Translocation and autophosphorylation of brain calmodulin kinase II in status epilepticus. Epilepsy Res 1992;9(Suppl.):231-8.
62. LIU H, MAZARATI A, BALDWIN RA, WASTERAIN CG. Tachykinin receptor trafficking in status epilepticus. Neurology 2003;60:A517.
63. SLOVITER RS. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 1987;235:73-6.
64. MELDRUM BS, HORTON RW. Physiology of status epilepticus in primates. Arch Neurol 1973;28:1-9.
65. MELDRUM BS, VIGOUROUX RA, BRIERLEY JB. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973;29:82-7.
66. POLLARD H, CHARRIAUT-MARLANGUE C, CANTAGREL S et al. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 1994;63:7-18.
67. SAKHI S, BRUCE A, SUN N, TOCCO G, BAUDRY M, SCHREIBER SS. p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci U S A 1994;91:7525-9.
68. COCK HR, TONG X, HARGREAVES IP et al. Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res 2002;48:157-68.
69. NIQUET J, BALDWIN RA, ALLEN SG, FUJIKAWA DG, WASTERLAIN CG. Hypoxic neuronal necrosis: protein synthesis-independent activation of a cell death program. Proc Natl Acad Sci U S A 2003;100:2825-30.
70. CORSELLIS JA, BRUTON CJ. Neuropathology of status epilepticus in humans. Adv Neurol 1983;34:129-39.
71. DEGIORGIO CM, CORREALE JD, GOTT PS et al. Serum neuron-specific enolase in human status epilepticus. Neurology 1995;45:1134-7.
72. DEGIORGIO CM, HECK CN, RABINOWICZ AL, GOTT PS, SMITH T, CORREALE J. Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology 1999;52:746-9.
73. CHU K, KANG DW, KIM JY, CHANG KH, LEE SK. Diffusion-weighted magnetic resonance imaging in nonconvulsive status epilepticus. Arch Neurol 2001;58:993-8.
74. WALKER MT, LEE SY. Profound neocortical atrophy after prolonged, continuous status epilepticus. AJR Am J Roentgenol 1999;173:1712-3.
75. SALMENPERA T, KALVIAINEN R, PARTANEN K, MERVAALA E, PITKANEN A. MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus. Epilepsy Res 2000;40:155-70.
76. CENDES F, ANDERMANN F, CARPENTER S, ZATORRE RJ, CASHMAN NR. Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in humans. Ann Neurol 1995;37:123-6.
77. A receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 2005;25:7724-33
78. WASTERLAIN CG, TREIMAN DM. Status epilepticus: mechanisms and management, 1st edn. Boston, MA: MIT Press, 2006.
79. MAZARATI AM, HOHMANN JG, BACON A et al. Modulation of hippocampal excitability and seizures by galanin. J Neurosci 2000;20:6276-81.